Top compounds associated with response to RRP9


Feature Type Standardized
Nominal ANOVA
mRNA Epothilone B GDSC1000 pan-cancer AAC 0.093 0.008
mRNA canertinib CTRPv2 pan-cancer AAC -0.097 0.009
mRNA PD173074 GDSC1000 pan-cancer AAC 0.094 0.009
mRNA navitoclax:PLX-4032 (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.094 0.009
mRNA lapatinib CTRPv2 pan-cancer AAC -0.095 0.009
mRNA Bosutinib GDSC1000 pan-cancer AAC 0.089 0.009
mRNA TAE684 CCLE pan-cancer AAC -0.12 0.009
mRNA STF-31 CTRPv2 pan-cancer AAC 0.094 0.009
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.095 0.009
mRNA WZ4002 CTRPv2 pan-cancer AAC -0.12 0.01
Download CSV